Tekmira begins limited manufacturing of drug targeting Ebola
(Reuters) – Canadian drugmaker Tekmira Pharmaceuticals Corp has begun limited manufacturing of a drug targeting the Ebola-Guinea virus that has killed more than 4,500 people, mostly in West Africa.
Read the original here:
Healthy Living News From around The Web
Tekmira begins limited manufacturing of drug targeting Ebola – Reuters
4746 S. Broadway
Wichita, Ks 67216